The effects of moderate-dose steroid therapy in sepsis: A placebo-controlled, randomized study

Journal of Research in Medical Sciences

Volumn 16, Issue 11, 2011, Pages 1410-1421

  Yildiz, Orhan ^a   Tanriverdi, Fatih ^a   Simsek, Serap ^a   Aygen, Bilgehan ^a   Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

ACTH; Adrenal insufficiency; Cortisol; Prednisolone; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOTROPIN; HYDROCORTISONE; PLACEBO; PREDNISOLONE; VASOACTIVE AGENT;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RELATIVE ADRENAL INSUFFICIENCY; SEPSIS; TREATMENT OUTCOME;

EID: 82955241241     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001; 29(7 Suppl): S109-S116.
2. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365(9453): 63-78.
3. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348(8): 727-34.
4. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, et al. Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 2007; 35(4): 1012-8.
5. Zaloga GP. Sepsis-induced adrenal deficiency syndrome. Crit Care Med 2001; 29(3): 688-90.
6. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283(8): 1038-45.
7. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337(8741): 582-3.
8. Briegel J, Schelling G, Haller M, Mraz W, Forst H, Peter K. A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996; 22(9): 894-9.
9. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995; 23(7): 1294-303.
10. Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010; 303(4): 341-8.
11. Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010; 182(18): 1971-7.
12. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supra-physiologic doses of hydrocortisone. Crit Care Med 1998; 26(4): 645-50.
13. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdy-namic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27(4): 723-32.
14. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288(7): 862-71.
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32(3): 858-73.
16. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, et al. Practice parameters for hemodynam-ic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32(9): 1928-48.
17. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358(2): 111-24.
18. Moran JL, Graham PL, Rockliff S, Bersten AD. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care 2010; 14(4): R134.
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20(6): 864-74.
20. Edsbacker S, Nilsson M, Larsson P. A cortisol suppression dose-response comparison of budesonide in controlled ileal release capsules with prednisolone. Aliment Pharmacol Ther 1999; 13(2): 219-24.
21. Ho KM, Lee KY, Williams T, Finn J, Knuiman M, Webb SA. Comparison of Acute Physiology and Chronic Health Evaluation (APACHE) II score with organ failure scores to predict hospital mortality. Anaesthesia 2007; 62(5): 466-73.
22. Kajdacsy-Balla Amaral AC, Andrade FM, Moreno R, Artigas A, Cantraine F, Vincent JL. Use of the sequential organ failure assessment score as a severity score. Intensive Care Med 2005; 31(2): 243-9.
23. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335(16): 1206-12.
24. Schein RM, Sprung CL, Marcial E, Napolitano L, Chernow B. Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18(3): 259-63.
25. Bouachour G, Tirot P, Gouello JP, Mathieu E, Vincent JF, Alquier P. Adrenocortical function during septic shock. Intensive Care Med 1995; 21(1): 57-62.
26. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17(1): 25-41.
27. Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ. Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 2002; 28(9): 1301-8.
28. Tanriverdi F, Senyurek H, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J Clin Endocrinol Metab 2006; 91(6): 2105-11.
29. Beishuizen A, Thijs LG, Vermes I. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 2002; 6(5): 434-8.
30. Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC. Systemic illness. Pituitary 2008; 11(2): 187-207.
31. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003; 31(1): 141-5.
32. Aygen B, Inan M, Doganay M, Kelestimur F. Adrenal functions in patients with sepsis. Exp Clin Endocrinol Diabetes 1997; 105(3): 182-6.
33. Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutuu A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 2002; 6(3): 251-9.
34. Schroeder S, Wichers M, Klingmuller D, Hofer M, Lehmann LE, von ST,et al. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med 2001; 29(2): 310-6.
35. Annane D. Effects of the combination of hydto- cottisone and fludtocottisone on mottality in septic shock. Ctit Cate Med 2000; 28: A63.